Literature DB >> 8424809

Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development.

S J Chung1, H L Fung.   

Abstract

We have shown previously that nitric oxide (NO) is generated from nitroglycerin (NTG) through enzyme-mediated reactions in the bovine coronary artery smooth muscle cell, but it is not known whether this metabolic conversion plays a significant role in the pharmacologic action of NTG, viz. relaxation. In this study, we developed a technique that allowed direct measurement of NO from intact bovine coronary arterial rings that were incubated previously with NTG, and examined whether changes in NTG-induced relaxation were accompanied by parallel changes in NO generation. Co-incubation of the vascular preparations with a potent inhibitor of glutathione-S-transferases (GSTs), bromosulfophthalein (up to 200 microM), did not affect NTG-induced relaxation, nor did it alter NO generation from NTG in the preparation. In contrast, 1-chloro-2,4-dinitrobenzene (CDNB), a GST substrate, inhibited NO generation as well as the relaxation response of NTG in the intact vascular tissue preparation. CDNB, however, did not decrease the relaxant responses of nifedipine and isoproterenol. Thus, the inhibitory effect of CDNB on NTG-induced relaxation and NO production appeared specific. When bovine coronary rings were made tolerant to NTG by pretreatment with 0.44 mM NTG for 1 hr, the EC50 was shifted to the right 162-fold, and NO generation was also reduced in intact rings and tissue homogenates. However, when the homogenates were further subfractionated to microsomes and cytosols, or when homogenates were allowed to stand for a similar time period necessary for subfractionation, the difference in NO production from control versus tolerant tissue preparations disappeared. It is possible, therefore, that the NTG-induced tolerance process might have been partially reversed during this time period. Results of this study identified CDNB as an apparently specific inhibitor of NTG action, but showed that GST-mediated reactions were probably not involved in the metabolic activation of NTG. Our results also indicated that tissue NO generation from NTG was positively related to the relaxation responses generated by this nitrovasodilator.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424809     DOI: 10.1016/0006-2952(93)90388-d

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

3.  Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure.

Authors:  J A Bauer; J P Balthasar; H L Fung
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

4.  Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.

Authors:  A L Jones; I H Bangash; J Walker; K J Simpson; N D Finlayson; P C Hayes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 5.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  Effect of nitric oxide on integrity, blood flow and cyclic GMP levels in the rat gastric mucosa: modulation by sialoadenectomy.

Authors:  M A Tripp; B L Tepperman
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

8.  Drinking rate in juvenile Atlantic salmon,Salmo salar L fry in response to a nitric oxide donor, sodium nitroprusside and an inhibitor of angiotensin converting enzyme, enalapril.

Authors:  J Fuentes; J C McGeer; F B Eddy
Journal:  Fish Physiol Biochem       Date:  1996-02       Impact factor: 2.794

Review 9.  Mechanisms of nitrate tolerance.

Authors:  H L Fung; J A Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

Review 10.  Short and long-acting oral nitrates for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.